Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)
Germany flag Germany · Delayed Price · Currency is EUR
2.500
0.00 (0.00%)
At close: Dec 4, 2025

Zylox-Tonbridge Medical Technology Company Description

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.

The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices.

Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products.

In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians.

The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021.

Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People’s Republic of China.

Zylox-Tonbridge Medical Technology Co., Ltd.
Country China
Founded 2012
Industry Surgical and Medical Instruments and Apparatus
Employees 875
CEO Zhong Zhao

Contact Details

Address:
Zylox-Tonbridge Industrial Park
Hangzhou
China
Phone 86 571 8861 0082
Website zyloxtb.com

Stock Details

Ticker Symbol 818
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 3841

Key Executives

Name Position
Zhong Zhao Chief Executive Officer
Quanwei Yuan Chief Financial Officer